Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
Environmental Microbiology
|
March 23, 2011
Microbial community structure of hydrothermal deposits from geochemically different vent fields along the Mid-Atlantic Ridge
Gilberto E Flores, James H Campbell, Julie D Kirshtein, et al.
Applied and Environmental Microbiology
|
April 16, 2021
Development of Wastewater Pooled Surveillance of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from Congregate Living Settings
Lisa M Colosi, Katie E Barry, Shireen M Kotay, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 3, 2005
3,3-Bisaryloxindoles as mineralocorticoid receptor antagonists
David A Neel, Matthew L Brown, Peter A Lander, et al.
American Indian and Alaska Native Mental Health Research (Online)
|
July 26, 2022
Lessons on Resilient Research: Adapting the Tribal Turning Point Study to COVID-19
Rachel I Steinberg, Joel A Begay, Paula M Begay, et al.
Pediatric Obesity
|
August 30, 2025
A Randomised Controlled Trial Testing a Behavioural Intervention Program for the Prevention of Type 2 Diabetes Among American Indian Youth: The Tribal Turning Point Study
Catherine C Cohen, Dana Dabelea, Madhumita Sinha, et al.
Journal of Medicinal Chemistry
|
November 28, 2007
(S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor
Michael G Bell, Douglas L Gernert, Timothy A Grese, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 8, 2013
Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer--8-year results of the Breast International Group 02-98 phase III trial
C Oakman, P A Francis, J Crown, et al.
Nature Communications
|
May 23, 2019
Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression
Lodoe Lama, Carolina Adura, Wei Xie, et al.
Bioorganic & Medicinal Chemistry
|
January 20, 2007
Azetidinones as vasopressin V1a antagonists
Christophe D Guillon, Gary A Koppel, Michael J Brownstein, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
Environmental Microbiology
|
March 23, 2011
Microbial community structure of hydrothermal deposits from geochemically different vent fields along the Mid-Atlantic Ridge
Gilberto E Flores, James H Campbell, Julie D Kirshtein, et al.
Applied and Environmental Microbiology
|
April 16, 2021
Development of Wastewater Pooled Surveillance of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from Congregate Living Settings
Lisa M Colosi, Katie E Barry, Shireen M Kotay, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 3, 2005
3,3-Bisaryloxindoles as mineralocorticoid receptor antagonists
David A Neel, Matthew L Brown, Peter A Lander, et al.
American Indian and Alaska Native Mental Health Research (Online)
|
July 26, 2022
Lessons on Resilient Research: Adapting the Tribal Turning Point Study to COVID-19
Rachel I Steinberg, Joel A Begay, Paula M Begay, et al.
Pediatric Obesity
|
August 30, 2025
A Randomised Controlled Trial Testing a Behavioural Intervention Program for the Prevention of Type 2 Diabetes Among American Indian Youth: The Tribal Turning Point Study
Catherine C Cohen, Dana Dabelea, Madhumita Sinha, et al.
Journal of Medicinal Chemistry
|
November 28, 2007
(S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor
Michael G Bell, Douglas L Gernert, Timothy A Grese, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 8, 2013
Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer--8-year results of the Breast International Group 02-98 phase III trial
C Oakman, P A Francis, J Crown, et al.
Nature Communications
|
May 23, 2019
Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression
Lodoe Lama, Carolina Adura, Wei Xie, et al.
Bioorganic & Medicinal Chemistry
|
January 20, 2007
Azetidinones as vasopressin V1a antagonists
Christophe D Guillon, Gary A Koppel, Michael J Brownstein, et al.
Page
of 10